BALDANTI, FAUSTO
 Distribuzione geografica
Continente #
NA - Nord America 6.190
EU - Europa 3.919
AS - Asia 2.482
AF - Africa 15
OC - Oceania 13
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 6
Totale 12.637
Nazione #
US - Stati Uniti d'America 6.146
CN - Cina 2.206
IE - Irlanda 1.550
IT - Italia 557
FI - Finlandia 452
UA - Ucraina 392
DE - Germania 319
SE - Svezia 254
GB - Regno Unito 201
SG - Singapore 146
FR - Francia 79
IN - India 56
JP - Giappone 40
CA - Canada 35
BE - Belgio 31
IR - Iran 18
NL - Olanda 15
RO - Romania 15
CZ - Repubblica Ceca 13
AU - Australia 12
RU - Federazione Russa 12
MU - Mauritius 11
CH - Svizzera 7
BR - Brasile 6
MX - Messico 6
AT - Austria 5
TR - Turchia 5
EU - Europa 4
GR - Grecia 4
AR - Argentina 3
ES - Italia 3
HK - Hong Kong 3
HR - Croazia 3
LV - Lettonia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
GT - Guatemala 2
IL - Israele 2
KR - Corea 2
MA - Marocco 2
PE - Perù 2
CL - Cile 1
DZ - Algeria 1
EG - Egitto 1
HN - Honduras 1
ID - Indonesia 1
MD - Moldavia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
TW - Taiwan 1
Totale 12.637
Città #
Dublin 1.529
Chandler 1.314
Ashburn 582
Jacksonville 571
Nanjing 503
Boardman 493
Princeton 288
Wilmington 280
Helsinki 261
Lawrence 257
Beijing 240
Nanchang 230
Shanghai 230
New York 215
Medford 188
Hebei 183
Shenyang 170
Changsha 150
Jiaxing 140
Ann Arbor 123
Hangzhou 104
Pavia 104
Milan 101
Tianjin 89
Woodbridge 82
Seattle 80
Singapore 77
Houston 61
Fairfield 56
Los Angeles 56
Pune 46
Washington 42
Norwalk 41
Tokyo 29
Toronto 29
Brussels 28
Falls Church 26
Rome 24
Dallas 19
Verona 19
Munich 18
Piscataway 18
San Francisco 16
Jinan 15
Ningbo 14
Zhengzhou 14
Redwood City 13
Auburn Hills 12
Chicago 11
Taizhou 11
Vicenza 11
Rivoli 10
Timisoara 10
Brno 9
Zanjan 9
Brescia 8
Frankfurt am Main 8
Lecce 8
Tappahannock 8
Turin 8
Borås 7
Cambridge 7
Falkenstein 7
Guangzhou 7
Berlin 6
Des Moines 6
Kunming 6
Taranto 6
Chiavari 5
Como 5
Florence 5
Melbourne 5
Orange 5
Varese 5
Vienna 5
Amsterdam 4
Cinisello Balsamo 4
Corsico 4
Fuzhou 4
Genoa 4
Lodi 4
London 4
Manerbio 4
Menlo Park 4
Motta Visconti 4
Olomouc 4
Redmond 4
Sacramento 4
Spoleto 4
Baoding 3
Bologna 3
Boves 3
Bovisio Masciago 3
Buenos Aires 3
Cascina 3
Ferrara 3
Ferrara di Monte Baldo 3
Gallarate 3
Laives 3
Legnano 3
Totale 9.467
Nome #
Adoptive transfer of herpesvirus-specific cytotoxic T lymphocytes in transplant recipients 98
Systematic analysis of human oncogenic viruses in colon cancer revealed EBV latency in lymphoid infiltrates. 88
Postinfectious neurologic syndromes: A prospective cohort study 86
Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: Need for mucosal viral load measurement. 81
T-lymphocytes with high proliferative capacity correlate with control of viral suppression in chronically untreated HIV-1 infected individual 81
Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection. 80
Accumulation of defective HIV-1 variants in a patient with slow disease progression. 77
A new Real-Time RT-PCR Assay for Detection of Human Enterovirus 68 (EV-D68) in Respiratory Samples. 77
Detection of haemagglutinin D222 polymorphisms in influenza A(H1N1)pdm09-infected patients by ultra-deep pyrosequencing. 77
Skewed B cells in chronic hepatitis C virus infection maintain their ability to respond to virus-induced activation 75
Compartmentalized replication of sars-cov-2 in upper vs. Lower respiratory tract assessed by whole genome quasispecies analysis 75
Diagnosis and counseling of fetal and neonatal HCMV infection. 73
Phylogenetic analysis of HIV type 1 CRF02_AG in multiple genes in Italian and African patients living in Italy. 71
Viral outbreaks in neonatal intensive care units: what we do not know. 71
A novel human enterovirus C (EV-C118) identified in two children hospitalised because of acute otitis media and community-acquired pneumonia in Israel. 71
Comparison of three different methods for the evaluation of IL28 and ITPA polymorphisms in patients infected with HCV. 70
Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting. 70
Differential outcome of neurological HCMV infection in two hematopoietic stem cell transplant recipients. 69
Herpes virus-6 chromosomal integration misled the management of Crohn’s disease 69
Persistent human cosavirus infection in lung transplant recipient, Italy. 69
Colitis in an elderly immunocompetent patient. 69
Imported hantavirus cardiopulmonary syndrome in an Italian traveller returning from Cuba. 68
Human enterovirus and parechovirus infections in newborns with sepsis-like illness and neurological disorders. 68
Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study group. 65
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 65
Surveillance and vaccination coverage of measles and rubella in Northern Italy. 64
Naturally occurring mutations to HCV protease inhibitors in treatment-naïve patients. 64
Toward the discovery of novel anti-HIV drugs. Second-generation inhibitors of the cellular ATPase DDX3 with improved anti-HIV activity: synthesis, structure-activity relationship analysis, cytotoxicity studies, and target validation. 64
Successful in vitro priming of EBV-specific CD8+ T cells endowed with strong cytotoxic function from T cells of EBV-seronegative children 64
Frequency of respiratory virus infections and next-generation analysis of influenza A/ H1N1pdm09 dynamics in the lower respiratory tract of patients admitted to the ICU 64
Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation 63
Possible role of viral reactivations in the lack of response to conventional therapies in patients with inflammatory bowel disease (IBS) 63
Mutations conferring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis. 62
Novel human enterovirus C infection in child with community-acquired Pneumonia. 62
Circulation of two Enterovirus C105 (EV-C105) lineages in Europe and Africa. 62
Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemtive therapy in bone marrow transplant recipients 62
Rising antigenemia levels may be misleading in pre-emptive therapy of human cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients 62
Cross-neutralization of four paramyxoviruses by a human monoclonal antibody. 62
Genome characterisation of enteroviruses 117 and 118: a new group within human enterovirus species C. 62
Complete genome characterization of enterovirus 104 circulating in Northern Italy shows recombinant origin of the P3 region. 62
Use of a DNAemia cut-off for monitoring human cytomegalovirus infection reduces the number of preemptively treated children and young adults receiving hematopoietic stem-cell transplantation compared with qualitative pp65 antigenemia. 62
Letter to the editor. Virological analysis of fatal influenza cases in the United Kingdom during the early wave of influenza in winter 2010/11. 61
Kinetics of human cytomegalovirus (HCMV) DNAemia in transplanted patients expressed in international units as determined with the Abbott RealTime CMV assay and an in-house assay. 61
Multiple ganciclovir-resistant strains in a newborn with symptomatic congenital human cytomegalovirus infection. 61
Dissociation between serum and liver hepatitis C virus RNA levels in patients coinfected with human immunodeficiency virus 61
Autologous human cytomegalovirus-specific cytotoxic T cells as rescue therapy for ulcerative enteritis in primary immunodeficiency 61
Virtual quantification of influenza A virus load by real-time RT-PCR. 61
Successful medical treatment of EBV smooth muscle tumor in a renal transplant recipient. 60
Prospective study of human metapneumovirus infection: diagnosis, typing and virus quantification in nasopharyngeal secretions from pediatric patients. 60
Xenotropic and polytropic murine leukemia virus-related sequences are not detected in the majority of patients with chronic fatigue syndrome. 60
Reconstruction of the evolutionary dynamics of the A(H1N1)pdm09 influenza virus in Italy during the pandemic and post-pandemic phases. 60
HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients. 60
Maternal, fetal, and neonatal parameters for prognosis and counseling of HCMV congenital infection. 60
Vaccination for seasonal influenza in patients with cancer: recommendations of the Italian Society of Medical Oncology (AIOM). 59
Severe outcome of influenza A/H1N1/09v infection associated with 222G/N polymorphisms in the haemagglutinin: a multicenter study. 59
Epstein-Barr Virus positive aggressive lymphoma as a consequence of immunosuppression after multiple salvage treatments for follicular lymphoma. 59
Acute cytomegalovirus infection as a cause of venous thromboembolism. 59
Expanding usutu virus circulation in italy: Detection in the Lazio region, central Italy, 2017 to 2018 59
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 59
Genotypic resistance profiles associated with virological failure to darunavir-containing regimens: a cross-sectional analysis. 58
Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies 58
Emerging and re-emerging virus infections in neonates and young pediatric patients. 58
Depletion of circulating IgM memory B cells predicts unfavourable outcome in COVID-19 58
Multiple clusters of A(H1N1)pdm09 virus circulating in severe cases of influenza during the 2010-2011 season: a phylogenetic and molecular analysis of the neuraminidase gene. 57
Discovery of the first small molecule inhibitor of human DDX3 specifically designed to target the RNA binding site: towards the next generation HIV-1 inhibitors. 57
Nevirapine-selected mutations Y1811/C of HIV-1 reverse transcriptase confer cross-resistance to stavudine 57
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 57
Different drug-resistant influenza A(H3N2) variants in two immunocompromised patients treated with oseltamivir during the 2011-2012 influenza season in Italy. 56
HCV intergenotype 2k/1b recombinant detected in a DAA-treated patient in Italy 56
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 56
Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection 56
Authors’ reply: Two severe human cases due to swine influenza a (H1N1)v in October 2016 in Europe were chronologic coincident yet distinct events 55
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count 55
Molecular detection of gastrointestinal viral infections in hospitalized patients. 54
Detection of Active Epstein-Barr Virus Infection in Duodenal Mucosa of Patients With Refractory Celiac Disease 54
The pentameric complex of human cytomegalovirus: Cell tropism, virus dissemination, immune response and vaccine development 54
Comparison of immunologic and molecular assays for the diagnosis of gastrointestinal viral infections. 54
Complete genome sequence of a novel human enterovirus C (HEV-C117) identified in a child with community-acquired pneumonia. 54
Kinetics of Epstein-Barr virus DNA load in different blood compartments of pediatric recipients of T-cell-depleted HLA-haploidentical stem cell transplantation. 53
Detection of Epstein-Barr virus-specific memory CD4+ T cells using a peptide-based cultured enzyme-linted immunospot assay. 53
Normalizing ELISPOT responses to T-cell counts: a novel approach for quantification of HCMV-specific CD4(+) and CD8(+) T-cell responses in kidney transplant recipients. 53
Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs 53
Segregation of virulent influenza A(H1N1) variants in the lower respiratory tract of critically ill patients during the 2010-2011 seasonal epidemic 53
Enterovirus-D68 (EV-D68) in pediatric patients with respiratory infection: The circulation of a new B3 clade in Italy 53
SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers 53
Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients. 52
T cell therapy of Epstein-Barr virus and adenovirus infections after hemopoietic stem cell transplant 52
Occult HIV infection in a large sample of health-care users in Lombardy, Italy in 2014-2015: Implications for control strategies 52
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis 52
Zika virus isolation from semen 51
Diagnosis and monitoring of human cytomegalovirus infection in transplant recipients 51
Cellular DNA quantification in respiratory samples for the normalization of viral load: a real need? 51
Incidence of SARS-CoV-2 infection in health care workers from Northern Italy based on antibody status: immune protection from secondary infection- A retrospective observational case-controlled study 51
West Nile Virus Outbreak in the Lombardy Region, Northern Italy, Summer 2013 51
12 weeks ombitasvir/paritaprevir–ritonavir + ribavirin achieve high SVR rates in HCV-4 patients with advanced fibrosis 50
Quantitation of human cytomegalovirus DNA in bone marrow transplant recipients 49
Chromosomally integrated human herpesvirus 6 in a patient with systemic lupus erythematosus. 49
Usutu Virus Antibodies in Blood Donors and Healthy Forestry Workers in the Lombardy Region, Northern Italy 49
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group. 49
FilmArray® respiratory panel performance in respiratory samples from neonatal care units. 49
Totale 6.140
Categoria #
all - tutte 63.423
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.423


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.520 0 941 3 69 1 78 15 77 12 171 148 5
2020/20211.122 94 81 96 72 10 120 52 228 77 145 107 40
2021/20221.251 23 14 27 46 52 29 33 65 72 42 179 669
2022/20234.084 405 278 77 280 328 348 13 203 1.828 41 207 76
2023/20242.453 279 396 101 128 253 598 184 159 29 100 107 119
2024/2025602 164 438 0 0 0 0 0 0 0 0 0 0
Totale 13.173